King's College London

Research portal

The story of NAIMIT - A framework 7 project on type 1 diabetes

Research output: Contribution to journalArticle

Chantal Mathieu, Lut Overbergh, Klaus Badenhoop, Penelope J. Bingley, Colin M. Dayan, Jocelyne Demengeot, Francesco Dotta, Decio L. Eizirik, Sigurd Lenzen, Piero Marchetti, Mark Peakman, Bart O. Roep, John Todd, Pieter Rottiers, Stephen Megit

Original languageEnglish
Pages (from-to)100-105
Number of pages6
JournalEuropean Journal of Endocrinology
Volume10
Issue number2
DOIs
Publication statusPublished - 2014

King's Authors

Abstract

NAIMIT (acronym for Natural Immune Modulation for Intervention in Type 1 Diabetes) is a large-scale collaborative programme of the 7th framework from the European Commission. The aim of the consortium is to bring together a group of leading European researchers spanning the field from genetics, through pancreatic beta-cell, dendritic cells and T-cell biology, towards clinical interventions. The ultimate goal is to develop novel and personalised interventional therapies in recent-onset type 1 diabetic patients, with minimal immune system interference, leading to beta-cell protection and restoration, based on a solid understanding of the disease pathogenesis, enabling experimental findings to be adopted for clinical applications.

View graph of relations

© 2018 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454